-
Watson Pharmaceuticals (WPI) was upgraded by UBS Friday to buy from neutral after announcing quarterly results on Thursday.
FORBES: Watson Gets Upgrade, $59 Target
-
Watson Pharmaceuticals (WPI): is now our top idea with a catalyst-heavy path and less crowded stock creating an attractive set-up here.
FORBES: Specialty Pharma: 5 Themes for 2012; 4 Best Stock Ideas
-
Late yesterday, Amgen (AMGN) and Watson Pharmaceuticals (WPI) said they will partner to develop and commercialize several oncology antibody biosimilar medicines.
FORBES: Cancer Drug Partnerships: Immunogen to Collaborate with Lilly, Amgen Partners with Watson
-
That's exactly the kind of break companies like Andrx and Watson Pharmaceuticals (nyse: WPI - news - people) yearn for.
FORBES: Magazine Article
-
"Firm CPI numbers raise upside risks for the WPI inflation number, especially on food costs, " said Radhika Rao, an economist at DBS Bank.
WSJ: India Factory Output Improves
-
The iShares Dow Jones U.S. Pharmaceuticals Index Fund (IHE) has Watson at 2.84% of its holdings and PowerShares Dynamic Pharmaceuticals Portfolio (PJP) is 2.8% WPI.
FORBES: Watson Gets Upgrade, $59 Target
-
At the same time Siu attended Worcester Polytechnic Institute (WPI) to study computer science, but after a visit to Boston he found the city more fun and more stimulating, and soon transferred to Boston University.
FORBES: Outblaze Sets Hong Kong Start-up Scene on Fire
-
Among the largest underlying components of FXH, in trading today Lincare Holdings Inc. ( NASD: LNCR) is trading flat, Watson Pharmaceuticals, Inc. ( NYSE: WPI) is up about 0.3%, and Forest Laboratories, Inc. ( NYSE: FRX) is higher by about 0.7%.
FORBES: FXH, LNCR, WPI, FRX: ETF Outflow Alert
-
Late yesterday, Bristol-Myers (nyse: BMY - news - people) said in a regulatory filing that inventory issues could hurt its 2002 earnings, which are already expected to be low, and added that it had settled a lawsuit brought by Watson Pharmaceuticals (nyse: WPI - news - people).
FORBES: Magazine Article